Fundraising Overview - The company raised a total of RMB 284,614,308.00, with a net amount of RMB 280,612,310.30 after deducting issuance costs [1][2] - As of June 30, 2025, the balance of the special account for raised funds was RMB 231,078,223.02 [1][2] Fund Management - The company has implemented strict management and usage protocols for the raised funds, adhering to relevant regulations and internal guidelines [1][4] - A tripartite supervision agreement was signed with the sponsor and the bank managing the special account [1][3] Fund Usage - A total of RMB 49,576,527.16 was invested in fundraising projects during the reporting period, with no changes in the purpose of the raised funds [2][4] - The company has not experienced any significant changes in the feasibility of the fundraising projects [2][4] Cash Management - The company has not used any temporarily idle raised funds for cash management during the reporting period [3][4] - A resolution was passed to allow the use of temporarily idle funds for cash management, but as of June 30, 2025, the balance for such management was RMB 0.00 [3][4] Loan to Subsidiary - The company approved a loan of up to RMB 26,000,000.00 to its subsidiary, Jiangsu Tianyan Medical Technology Co., Ltd., for project implementation [3][4] Compliance and Disclosure - The company has complied with all relevant laws and regulations regarding the use of raised funds and has disclosed the usage status in a timely manner [4]